Introduction G4.5 gene is a small single-copy gene with a complex pattern of expression. As many as 10 mRNAs differing The dilated cardiomyopathies are a very heterogeneous either in the region encoded in the central exons (5-7) group of heart disorders of largely unknown ethiology. or in the 5 end can be synthesized. Two forms, conGenetic causes have become increasingly evident with taining all three exons or lacking exon 5 only, were mapping of loci and identification of genes responsible consistently more abundant and ubiquitously expressed.
Since the differently spliced mRNAs maintain the same open reading frame (ORF), the tafazzins, the putative they would not interfere with the synthesis of all the two of the patients (BS and GW) and seems to have increased life expectancy. possible tafazzins. We now report the study of a larger group, of patients affected with BTHS and of patients
In the search for mutations, PCR products were prepared from genomic DNA of either one patient or an affected with severe cardiac disorders compatible with X-linked inheritance. We show that mutations are to be obligate carrier from each family and were sequenced directly, as described elsewhere (Bione et al. 1996) . Mufound also in this group of patients and that the G4.5 gene is responsible for most of the X-linked infantile tations were found in six of the familial cases, and they are listed in table 1; their localizations with respect to dilated cardiomyopathies. the G4.5 gene are shown in figure 1 . Some of the corresponding sequences are shown, aligned with the normal Material and Methods sequence, in figure 2.
Mutation Detection
Two new mutations were found in exon 2, one was in exon 6, and the remaining three were in exon 8. One Genomic DNA preparation, amplification, and direct sequencing of the BTHS gene were as described else-of the mutations in exon 2 (family 1) was a deletion causing a frameshift and early stop; all the remaining where (Bione et al. 1996) . Sequences were from the primers described, and they were designed to sequence mutations were missense. As a control for polymorphism, 100 chromosomes from normal individuals were all exons and exon-intron junctions from both strands. As a control for PCR errors, at least two independent sequenced in the region of the mutations, and they were all normal. On the other hand, additional affected indi-PCR products were sequenced in the region of each mutation. The sequence of each patient was always com-viduals and obligate carriers, when available, were sequenced, and the mutations were all confirmed. In fampared with that of at least one normal individual, in the same gel. As a control for polymorphism, all the ily 1 we sequenced the mother's DNA; in family 6 the mother's and the grandmother's DNAs; in family 8 the mutations were searched in DNA from 100 normal chromosomes randomly selected among different popumother's and the sister's DNAs; and in family 9 the mother's, the aunt's, and a normal brother's DNAs. lations available to the laboratory and containing both males and females.
In the remaining two families, published as putative BTHS (families 11 and 12; Ö rstavik et al. 1993) , no Sequence Analysis mutations were found. Since only the coding region and Sequence reactions were run in a Perkin Elmer 373A the splice junctions were studied, and since only the Automated Sequencer, and they were analyzed by use DNAs of obligate carriers were available, we cannot of SeqEd and Sequence Navigator software. Sequences absolutely exclude an involvement of the G4.5 gene. were compared with the GenBank sequences by use of Four sporadic patients were also studied, and no muta-BLAST, and they were aligned with CLUSTAL.
tions were found.
X-Linked Infantile Cardiomyopathies: Mutations in the Results

BTHS Gene Mutation Analysis of BTHS Patients
Gedeon et al. (1995) reported a large family presenting with X-linked inheritance of a fatal infantile cardioIn our previous work we studied patients from four families affected with BTHS. To gain more information myopathy. The gene was mapped to Xq28. The cardiomyopathy in this family is consistently of congenital on the mutations causing this disorder, we collected eight additional cases. Some were definitely familial. In onset and is fatal in infancy. The clinical features were insufficient to permit a definite diagnosis, but the possiother families relatives were reported as possibly affected, but the disease could not be well defined before bility that this disease is allelic with BTHS was discussed.
We sequenced the G4.5 gene in two affected individuals death occurred. Some of the clinical manifestations of the propositi of each family are schematically listed in of the family, and we found deletion of a C at position 919 in exon 8, causing frameshift and a stop codon after table 1. Other affected family members were usually studied less thoroughly and are not reported in the table: 18 nucleotides (patient MH in fig. 1 ). The mutation may cause the production of a truncated protein or, possibly, some of the families were previously published, and more data are available from the literature. In all fami-a reduced amount of the corresponding mRNAs and therefore no protein at all (Maquat 1995). lies, cardiac dilatation and cardiac failure within the 1st year of life were the common feature. Neutropenia
We have also studied patients from two families with several affected male relatives (brothers and cousins) (usually cyclic or episodic), myopathy, growth retardation, and alterations in urinary 3-methylglutaconic acid who died very early of heart failure. The clinical data were very limited, but after autopsy these patients' (Kelley et al. 1991) were consistently reported. Life expectancy was very variable, possibly depending on medi-hearts showed left-ventricular dilatation and hypertrophy, and they were diagnosed as affected with EFE1. cal treatment. Cardiac transplantation was reported in (IV-4), had cardiac failure at age 5 wk, survived, and (Lindenbaum et al. 1973 ). In the second large and yetunpublished family ( fig. 3 ), four affected males were now, at age 25 years, is normal. In both families we found the same mutation (a GrA change at nucleotide described: three (IV-1, IV-16, and V-5) died within the 1006) in exon 10, causing a GrR change in the sequence of the protein (G240R). The mutation was not found in 100 normal chromosomes. In the family studied by Lindenbaum et al., the mutation was found in three obligate carriers. In the family of SWH, all the patients and the mother (II-1) of SWH were sequenced and shown to carry the mutation.
Missense Mutations: Change of Conserved Amino Acids The G4.5 gene is conserved in evolution. A BLAST search of GenBank showed that ORFs encoding very similar protein sequences exist in Caenorhabditis elegans and Saccharomyces cerevisiae genomes. The alignment of the tafazzins from the three organisms is shown in figure 4 . The region corresponding to the alternative exon 5 in human is missing in the C. elegans gene; in S. cerevisiae the corresponding region is present, but it is not conserved. Striking conservation was observed in most of the rest of the protein. The four regions boxed in figure 4 are the most conserved: ú50% of the amino acids are identical between the three species, and ú80% are conservative substitutions. The missense mutations found in the patients are indicated in figure 4 , and in all instances they correspond to residues conserved between two or all three organisms. No function is known for the C. elegans or S. cerevisiae tafazzins, since they correspond to ORFs identified by genomic sequencing. of mutations in the BTHS gene, G4.5. We show that Numbers correspond to nucleotide positions in the cDNA (Bione et al. 1996) . Arrowheads point to mutations. A 13-base deletion is boxed. mutations in this gene are found in BTHS and in other affected with either EFE1 or severe cardiomyopathy have not been as thoroughly studied, and they were just described as affected with dilated cardiomyopathy. Whether the other symptoms of BTHS were present cannot be established with the available clinical data, but our findings suggest that mutations in the G4.5 gene have to be considered as a possible cause of infantile dilated cardiomyopathies affecting males, even in the absence of the typical BTHS signs.
Seven different mutations have been reported in this work. They were searched and not found in 100 normal Figure 3 Pedigree of family SWH. The asterisk (*) indicates the chromosomes, and, when DNA of family members was carrying the mutation. Blackene boxes denote available, they were shown to segregate with the disease. affected males; and diagonally striped boxes denote males who died
The 11 mutations described thus far in the BTHS gene of heart disorder different from BTHS.
are null or missense mutations localized in alternative, as well as in invariant, parts of the gene. Both missense and null mutations seem to be responsible for a similar X-linked dilated cardiomyopathies, previously considered disease, since the clinical characteristics and life expecdifferent conditions and listed with different OMIM tancy of the patients in each BTHS family do not appear numbers (305300 and 300069). The patients diagnosed to profoundly differ. This is unlike the situation in many as affected with BTHS were often well characterized, and other disorders, where missense often causes a phenoat least one patient in each family was thoroughly studied. type less severe than that caused by null mutations. We have tried to summarize the most common features However, since comparison with similar sequences in of the disease, and the data in table 1 demonstrate that, distant species has indicated that the amino acids in addition to cardiac failure in the 1st year of life, growth changed by the mutations are highly conserved residues, arrest, cyclic neutropenia, and methylglutaconic aciduria the very severe effect of missense mutations could be ascribed to a drastic structural modification of the proappear to be reliable diagnostic signs of BTHS. Patients
Figure 4
Alignment of amino acid sequence of tafazzins with C. elegans and S. cerevisiae homologues, done by use of CLUSTAL. Asterisks (*) indicate identical amino acids; and dots indicate conserved amino acids. Highly conserved regions are boxed; and amino acids changed in the patients indicated are in boldface.
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